Neil Averitt commentary: The curious case of Hims & Hers
The Federal Trade Commission has sued lifestyle pharmaceutical marketer Hims & Hers on multiple charges, most involving its negative-option subscriptions. These charges seem valid, but the consumer harm is limited, raising...To view the full article, register now.
Already a subscriber? Click here to view full article